Of the following agents intended for treating rheumatoid arthritis (RA), which is FDA-indicated for treating adults with moderately to severely active RA who have had an inadequate response to one or more tumor necrosis factor (TNF) inhibitors?

Baricitinib
Tofacitinib
Upadacitinib
Filgotinib

Congratulations to our July Winner!

Dr. L.D., Dermatologist from CT